An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of tec family kinases

Allergology International

Volumn 56, Issue 4, 2007, Pages 403-409

  Kawakami, Yuko ^a,b   Yumoto, Kenji ^a   Kawakami, Toshiaki ^a,b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b Allimmune LLC   (United States)

Author keywords

Allergen; Atopic dermatitis; Mite; Tec; Th2

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; DEXAMETHASONE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE; PROTEIN KINASE TEC; STAPHYLOCOCCUS ENTEROTOXIN B; TERREIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INBRED STRAIN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN DEFECT;

EID: 37349026664     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-07-486     Document Type: Article

References (33)

1. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J. Clin. Invest. 2004;113:651-657.
2. Wollenberg A, Bieber T. Atopic dermatitis: from the genes to skin lesions. Allergy 2000;55:205-213.
3. Grewe M, Bruijnzeel-Koomen CA, Schopf E et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today 1998;19:359-361.
4. Tsicopoulos A, Hamid Q, Haczku A et al. Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals. J. Allergy Clin. Immunol. 1994; 94:764-772.
5. Werfel T, Morita A, Grewe M et al. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J. Invest. Dermatol. 1996;107:871-876.
6. Thepen T, Langeveld-Wildschut EG, Bihari IC et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J. Allergy Clin. Immunol. 1996;97:828-837.
7. Akdis CA, Akdis M, Trautmann A, Blaser K. Immune regulation in atopic dermatitis. Curr. Opin. Immunol. 2000;12:641-646.
8. Strange P, Skov L, Lisby S et al. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch. Dermatol. 1996;132:27-33.
9. Jappe U. Superantigens and their association with dermatological inflammatory diseases: facts and hypotheses. Acta Derm. Venereol. 2000;80:321-328.
10. Matsuda H, Watanabe N, Geba GP et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 1997;9:461-466.
11. Spergel JM, Mizoguchi E, Brewer JP et al. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 1998;101:1614-1622.
12. Chan LS, Robinson N, Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J. Invest. Dermatol. 2001;117: 977-983.
13. Yamanaka K, Tanaka M, Tsutsui H et al. Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J. Immunol. 2000;165:997-1003.
14. Konishi H, Tsutsui H, Murakami T et al. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc. Natl. Acad. Sci. U.S.A. 2002;99:11340-11345.
15. Klement JF, Rice NR, Car BD et al. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol. Cell Biol. 1996; 16:2341-2349.
16. Barton D, HogenEsch H, Weih F. Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur. J. Immunol. 2000;30:2323-2332.
17. Spergel JM, Mizoguchi E, Oettgen H et al. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest. 1999;103:1103-1111.
18. Vestergaard C, Yoneyama H, Murai M et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 1999; 104:1097-1105.
19. Iijima OT, Takeda H, Komatsu Y et al. Atopic dermatitis in NC/Jic mice associated with Myobia musculi infestation. Comp. Med. 2000;50:225-228.
20. Morita E, Kaneko S, Hiragun T et al. Fur mites induce dermatitis associated with IgE hyperproduction in an inbred strain of mice, NC/Kuj. J. Dermatol. Sci. 1999;19:37-43.
21. Gao XK, Nakamura N, Fuseda K et al. Establishment of allergic dermatitis in NC/Nga mice as a model for severe atopic dermatitis. Biol. Pharm. Bull. 2004;27:1376-1381.
22. Heishi M, Imai Y, Katayama H et al. Gene expression analysis of atopic dermatitis-like skin lesions induced in NC/Nga mice by mite antigen stimulation under specific pathogen-free conditions. Int. Arch. Allergy Immunol. 2003;132:355-363.
23. Kang JS, Lee K, Han SB et al. Induction of atopic eczema/ dermatitis syndrome-like skin lesions by repeated topical application of a crude extract of Dermatophagoides pteronyssinus in NC/Nga mice. Int. Immunopharmacol. 2006; 6:1616-1622.
24. Matsuoka H, Maki N, Yoshida S et al. A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy 2003;58:139-145.
25. Unno T, Suto H, Yoshiike T et al. [Induction of atopic dermatitis-like skin lesion in NC/Nga mice - the influence of the skin barrier destroying solution to the induction of dermatitis]. Arerugi 2001;50:1152-1162 (in Japanese).
26. Kawakami Y, Hartman SE, Kinoshita E et al. Terreic acid, a quinone epoxide inhibitor of Bruton's tyrosine kinase. Proc. Natl. Acad. Sci. U.S.A. 1999;96:2227-2232.
27. Tanaka T, Tsutsui H, Yoshimoto T et al. Interleukin-18 is elevated in the sera from patients with atopic dermatitis and from atopic dermatitis model mice, NC/Nga. Int. Arch. Allergy Immunol. 2001;125:236-240.
28. Barnes PJ. Therapeutic strategies for allergic diseases. Nature 1999;402:B31-38.
29. Yang WC, Collette Y, Nunes JA, Olive D. Tec kinases: a family with multiple roles in immunity. Immunity 2000; 12:373-382.
30. Yagi R, Nagai H, Iigo Y et al. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J. Immunol. 2002;168:2020-2027.
31. Kanner SB, Perez-Villar JJ. Altering T-cell activation by targeting the multidomain tyrosine kinase Itk. Trends Immunol. 2003;24:249-253.
32. Wollenberg A, Wetzel S, Burgdorf WH, Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J. Allergy Clin. Immunol. 2003;112:667-674.
33. Engler RJ, Kenner J, Leung DY. Smallpox vaccination: Risk considerations for patients with atopic dermatitis. J. Allergy Clin. Immunol. 2002;110:357-365.